Twist Property Plant And Equipment Net vs Total Assets Analysis

TWST Stock

USD 47.01 0.51 1.10%

Twist Bioscience financial indicator trend analysis is much more than just breaking down Twist Bioscience Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Twist Bioscience Corp is a good investment. Please check the relationship between Twist Bioscience Property Plant And Equipment Net and its Total Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Property Plant And Equipment Net vs Total Assets

Property Plant And Equipment Net vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Twist Bioscience Corp Property Plant And Equipment Net account and Total Assets. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Twist Bioscience's Property Plant And Equipment Net and Total Assets is 0.89. Overlapping area represents the amount of variation of Property Plant And Equipment Net that can explain the historical movement of Total Assets in the same time period over historical financial statements of Twist Bioscience Corp, assuming nothing else is changed. The correlation between historical values of Twist Bioscience's Property Plant And Equipment Net and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Net of Twist Bioscience Corp are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Property Plant And Equipment Net i.e., Twist Bioscience's Property Plant And Equipment Net and Total Assets go up and down completely randomly.

Correlation Coefficient

0.89

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Total Assets

Total assets refers to the total amount of Twist Bioscience assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Twist Bioscience Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most indicators from Twist Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Twist Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

At this time, Twist Bioscience's Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 1.19 in 2024, whereas Selling General Administrative is likely to drop slightly above 109.9 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	333.3M	296.6M	341.1M	170.8M
Cost Of Revenue	119.3M	155.4M	178.7M	187.6M

Total Operating Expenses Cost Of Revenue

Twist Bioscience fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory
Total Assets		0.9	0.7	0.99	0.94	0.27	0.91	0.89	0.65	-0.85	-0.93	0.94	0.93	0.87	0.83	0.26	-0.88	0.96	0.9	0.83	0.98	0.39	-0.75	-0.53	0.92	0.94
Short Long Term Debt Total	0.9		0.59	0.89	0.96	0.11	0.98	1.0	0.8	-0.76	-0.96	0.83	0.82	0.99	0.75	0.09	-0.84	0.84	0.98	0.97	0.9	0.32	-0.72	-0.45	0.98	0.97
Other Current Liab	0.7	0.59		0.7	0.64	0.02	0.57	0.62	0.05	-0.62	-0.56	0.72	0.64	0.61	0.32	0.01	-0.51	0.7	0.53	0.59	0.56	0.4	-0.41	-0.23	0.57	0.66
Total Current Liabilities	0.99	0.89	0.7		0.93	0.24	0.91	0.89	0.65	-0.84	-0.94	0.97	0.92	0.88	0.85	0.24	-0.89	0.95	0.9	0.84	0.98	0.4	-0.75	-0.54	0.92	0.94
Total Stockholder Equity	0.94	0.96	0.64	0.93		0.24	0.99	0.95	0.77	-0.82	-0.96	0.88	0.87	0.93	0.77	0.22	-0.93	0.93	0.97	0.89	0.92	0.48	-0.87	-0.65	0.99	0.98
Other Liab	0.27	0.11	0.02	0.24	0.24		0.15	0.03	0.22	-0.67	-0.13	0.29	0.57	0.0	0.43	1.0	-0.29	0.45	0.11	-0.08	0.23	-0.21	-0.23	-0.21	0.16	0.26
Net Tangible Assets	0.91	0.98	0.57	0.91	0.99	0.15		0.97	0.82	-0.76	-0.97	0.85	0.82	0.96	0.77	0.14	-0.91	0.88	0.99	0.93	0.92	0.44	-0.84	-0.61	1.0	0.97
Property Plant And Equipment Net	0.89	1.0	0.62	0.89	0.95	0.03	0.97		0.78	-0.72	-0.96	0.83	0.79	1.0	0.73	0.02	-0.83	0.81	0.97	0.99	0.89	0.33	-0.71	-0.44	0.98	0.96
Current Deferred Revenue	0.65	0.8	0.05	0.65	0.77	0.22	0.82	0.78		-0.56	-0.83	0.59	0.61	0.77	0.79	0.22	-0.78	0.61	0.85	0.75	0.75	0.19	-0.66	-0.49	0.84	0.77
Net Debt	-0.85	-0.76	-0.62	-0.84	-0.82	-0.67	-0.76	-0.72	-0.56		0.76	-0.87	-0.97	-0.7	-0.8	-0.66	0.78	-0.92	-0.73	-0.64	-0.79	-0.12	0.61	0.4	-0.77	-0.87
Retained Earnings	-0.93	-0.96	-0.56	-0.94	-0.96	-0.13	-0.97	-0.96	-0.83	0.76		-0.88	-0.83	-0.95	-0.85	-0.13	0.92	-0.87	-0.98	-0.92	-0.95	-0.39	0.76	0.52	-0.98	-0.96
Accounts Payable	0.94	0.83	0.72	0.97	0.88	0.29	0.85	0.83	0.59	-0.87	-0.88		0.92	0.83	0.86	0.31	-0.86	0.92	0.84	0.79	0.91	0.29	-0.67	-0.45	0.87	0.92
Cash	0.93	0.82	0.64	0.92	0.87	0.57	0.82	0.79	0.61	-0.97	-0.83	0.92		0.77	0.85	0.55	-0.81	0.95	0.8	0.72	0.89	0.17	-0.65	-0.43	0.83	0.91
Non Current Assets Total	0.87	0.99	0.61	0.88	0.93	0.0	0.96	1.0	0.77	-0.7	-0.95	0.83	0.77		0.72	-0.02	-0.8	0.79	0.96	0.99	0.87	0.29	-0.68	-0.41	0.96	0.95
Non Currrent Assets Other	0.83	0.75	0.32	0.85	0.77	0.43	0.77	0.73	0.79	-0.8	-0.85	0.86	0.85	0.72		0.45	-0.85	0.81	0.8	0.68	0.9	0.13	-0.56	-0.36	0.8	0.83
Other Assets	0.26	0.09	0.01	0.24	0.22	1.0	0.14	0.02	0.22	-0.66	-0.13	0.31	0.55	-0.02	0.45		-0.3	0.44	0.11	-0.09	0.23	-0.2	-0.22	-0.2	0.15	0.26
Long Term Debt	-0.88	-0.84	-0.51	-0.89	-0.93	-0.29	-0.91	-0.83	-0.78	0.78	0.92	-0.86	-0.81	-0.8	-0.85	-0.3		-0.91	-0.93	-0.74	-0.91	-0.58	0.82	0.64	-0.92	-0.9
Cash And Short Term Investments	0.96	0.84	0.7	0.95	0.93	0.45	0.88	0.81	0.61	-0.92	-0.87	0.92	0.95	0.79	0.81	0.44	-0.91		0.86	0.72	0.93	0.45	-0.78	-0.59	0.88	0.92
Net Receivables	0.9	0.98	0.53	0.9	0.97	0.11	0.99	0.97	0.85	-0.73	-0.98	0.84	0.8	0.96	0.8	0.11	-0.93	0.86		0.93	0.92	0.45	-0.78	-0.54	0.99	0.97
Good Will	0.83	0.97	0.59	0.84	0.89	-0.08	0.93	0.99	0.75	-0.64	-0.92	0.79	0.72	0.99	0.68	-0.09	-0.74	0.72	0.93		0.83	0.25	-0.63	-0.36	0.93	0.92
Common Stock Shares Outstanding	0.98	0.9	0.56	0.98	0.92	0.23	0.92	0.89	0.75	-0.79	-0.95	0.91	0.89	0.87	0.9	0.23	-0.91	0.93	0.92	0.83		0.39	-0.74	-0.52	0.93	0.93
Short Term Investments	0.39	0.32	0.4	0.4	0.48	-0.21	0.44	0.33	0.19	-0.12	-0.39	0.29	0.17	0.29	0.13	-0.2	-0.58	0.45	0.45	0.25	0.39		-0.62	-0.64	0.42	0.33
Long Term Debt Total	-0.75	-0.72	-0.41	-0.75	-0.87	-0.23	-0.84	-0.71	-0.66	0.61	0.76	-0.67	-0.65	-0.68	-0.56	-0.22	0.82	-0.78	-0.78	-0.63	-0.74	-0.62		0.94	-0.81	-0.74
Non Current Liabilities Total	-0.53	-0.45	-0.23	-0.54	-0.65	-0.21	-0.61	-0.44	-0.49	0.4	0.52	-0.45	-0.43	-0.41	-0.36	-0.2	0.64	-0.59	-0.54	-0.36	-0.52	-0.64	0.94		-0.57	-0.49
Capital Surpluse	0.92	0.98	0.57	0.92	0.99	0.16	1.0	0.98	0.84	-0.77	-0.98	0.87	0.83	0.96	0.8	0.15	-0.92	0.88	0.99	0.93	0.93	0.42	-0.81	-0.57		0.98
Inventory	0.94	0.97	0.66	0.94	0.98	0.26	0.97	0.96	0.77	-0.87	-0.96	0.92	0.91	0.95	0.83	0.26	-0.9	0.92	0.97	0.92	0.93	0.33	-0.74	-0.49	0.98

Click cells to compare fundamentals

Twist Bioscience Account Relationship Matchups

Twist Bioscience fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	398.9M	702.1M	961.4M	776.4M	892.9M	454.3M
Short Long Term Debt Total	36.0M	62.9M	94.9M	94.1M	108.2M	113.6M
Other Current Liab	2.6M	9.6M	53.5M	7.8M	9.0M	11.3M
Total Current Liabilities	36.0M	63.1M	90.7M	73.3M	84.3M	45.4M
Total Stockholder Equity	336.3M	580.8M	789.4M	623.4M	716.9M	752.8M
Other Liab	158K	351K	5.1M	60K	69K	65.6K
Net Tangible Assets	150.4M	334.8M	540.1M	789.4M	907.8M	953.2M
Property Plant And Equipment Net	59.2M	105.7M	214.4M	203.4M	233.9M	245.6M
Current Deferred Revenue	18.8M	28.8M	3.5M	36.6M	42.1M	44.2M
Net Debt	(57.7M)	(402.9M)	(283.8M)	(192.4M)	(173.2M)	(181.8M)
Retained Earnings	(458.5M)	(610.6M)	(828.4M)	(1.0B)	(929.7M)	(883.2M)
Accounts Payable	4.8M	14.9M	20.1M	14.1M	16.2M	10.5M
Cash	93.7M	465.8M	378.7M	286.5M	329.4M	194.1M
Non Current Assets Total	64.0M	155.6M	364.9M	352.1M	405.0M	425.2M
Non Currrent Assets Other	3.4M	9.2M	5.0M	8.5M	9.8M	5.2M
Other Assets	4.4M	3.4M	49.9M	(1K)	(1.2K)	(1.1K)
Cash And Short Term Investments	290.0M	477.9M	505.0M	336.4M	386.9M	267.6M
Net Receivables	26.4M	28.5M	40.3M	44.1M	50.7M	53.2M
Common Stock Shares Outstanding	39.2M	48.3M	53.9M	56.9M	65.4M	39.9M
Short Term Investments	196.3M	12.0M	126.3M	49.9M	57.4M	73.5M
Liabilities And Stockholders Equity	398.9M	702.1M	961.4M	776.4M	892.9M	454.3M
Non Current Liabilities Total	26.6M	58.2M	81.3M	79.6M	71.7M	90.3M
Capital Surpluse	470.4M	794.6M	1.2B	1.6B	1.9B	2.0B
Inventory	12.3M	31.8M	39.3M	32.1M	36.9M	38.7M
Other Current Assets	6.2M	8.3M	11.9M	11.7M	13.5M	14.1M
Other Stockholder Equity	794.6M	1.2B	1.6B	1.7B	1.9B	2.0B
Total Liab	62.6M	121.3M	172.0M	153.0M	137.7M	123.3M
Property Plant And Equipment Gross	59.2M	105.7M	214.4M	203.4M	233.9M	245.6M
Total Current Assets	334.9M	546.5M	596.5M	424.3M	487.9M	314.2M
Non Current Liabilities Other	25.2M	58.2M	60K	475K	546.3K	518.9K
Short Term Debt	9.7M	9.8M	13.6M	14.9M	17.1M	8.9M
Intangible Assets	307K	18.3M	59.7M	54.5M	62.7M	65.8M
Property Plant Equipment	20.8M	25.5M	44.1M	214.4M	246.5M	258.9M
Net Invested Capital	341.0M	1.6M	789.4M	623.4M	716.9M	752.8M

When determining whether Twist Bioscience Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Twist Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Twist Bioscience Corp Stock. Highlighted below are key reports to facilitate an investment decision about Twist Bioscience Corp Stock:

How To Invest In Twist

Details

Is Twist Stock a good investment?

Details

What is Twist Bioscience's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Twist Stock analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.

	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Global Correlations Find global opportunities by holding instruments from different markets
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Commodity Directory Find actively traded commodities issued by global exchanges
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments

Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.36)

Revenue Per Share

4.834

Quarterly Revenue Growth

0.251

Return On Assets

(0.16)

Return On Equity

(0.30)

The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Twist Property Plant And Equipment Net vs Total Assets Analysis

Property Plant And Equipment Net vs Total Assets

Property Plant And Equipment Net vs Total Assets Correlation Analysis

Correlation Coefficient

Property Plant And Equipment Net

Total Assets

Twist Bioscience fundamental ratios Correlations

Twist Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Twist Bioscience fundamental ratios Accounts

Complementary Tools for Twist Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 1.0	Short Long Term Debt Total
Other Assets	+ 1.0	Other Liab
Capital Surpluse	+ 1.0	Net Tangible Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Liabilities	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Short Long Term Debt Total

Capital Surpluse	- 0.98	Retained Earnings
Net Receivables	- 0.98	Retained Earnings
Cash	- 0.97	Net Debt
Retained Earnings	- 0.97	Net Tangible Assets
Inventory	- 0.96	Retained Earnings
Retained Earnings	- 0.96	Property Plant And Equipment Net